ABSTRACT: Allergic conjunctivitis (AC) is a common ocular surface allergic disease with a rising global incidence, significantly impacting patients’ quality of life. Traditional diagnosis primarily ...

MILAN & SAN MATEO, Calif.--(BUSINESS WIRE)--Dompé, a leading biopharmaceutical company with operations in Italy and the U.S., announced the first patients have been enrolled in a Phase 3 study of ...

Menotrophin prefilled pen for treating anovulation or during controlled ovarian hyperstimulation [TSID12290] Medicines evaluation Not selected 12 December 2025 Cyclosporin eye drops for treating ...

Please provide your email address to receive an email when new articles are posted on . Click here to read the Cover Story, "Pediatric board addresses when to start myopia treatment, alternatives to ...

Correspondence to Dr Sirisha Senthil, VST Glaucoma Center, L V Prasad Eye Institute, Hyderabad 500034, India; sirishasenthil{at}lvpei.org Purpose To report the clinical features, treatment outcomes ...

Epidemic keratoconjunctivitis is inflammation of conjunctiva, the membrane covering the sclera (white outer coating of the eye) and inside of the eyelids, usually caused by specific strains of a group ...

Aim To analyse the clinical and demographic profiles of patients with vernal keratoconjunctivitis (VKC) and propose a grading for VKC based on corneal status and symptom periodicity rather than ...

Seinda Pharmaceutical is a developer of precision medicine through biomarker research developing diagnostics and therapeutic medicines for eye disorders. The company is headquartered in Guangzhou, ...

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, ...

Vernal keratoconjunctivitis (VKC) is an ocular disorder characterized by severe inflammation affecting both the cornea and conjunctiva that mainly affects boys in the first decade of life. Although ...